Volume s1-24, Issue 1
  • ISSN: 0002-9637
  • E-ISSN: 1476-1645


At this time when there is need for a careful appraisal of all available amebacides because of their extensive use by the armed forces, additional experimental and clinical data on such drugs seems appropriate. When iodochlorhydroxyquinoline (Vioform N.N.R.) was introduced as an amebacide it was stated, in summarizing the preliminary experimental work that of some eleven halogenated hydroxyquinolines this drug appeared the most promising for further study, with the possible exception of diiodohydroxyquinoline (Diodoquin) (1). Since then, Vioform has been used extensively both as an amebacide and a trichomonacide (2) and, recently, Diodoquin has been recommended for the same purposes (3). However, further experimental chemotherapeutic studies on Diodoquin appear to be lacking except for Tenney's (4) report that no untoward symptoms developed in dogs given oral doses of Diodoquin ranging from 4.0 to 6.0 grams per day for a period of six days.


Article metrics loading...

The graphs shown below represent data from March 2017
Loading full text...

Full text loading...

  • Received : 19 Apr 1943
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error